Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-discovers-children-with-autism-have-delayed-gut-microbiome-maturity-and-identifies-faecal-bacterial-markers-for-autism
https://www.med.cuhk.edu.hk/press-releases/cuhk-discovers-children-with-autism-have-delayed-gut-microbiome-maturity-and-identifies-faecal-bacterial-markers-for-autism

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) reports a ground breaking discovery that children with autism spectrum disorder (autism) showed delayed gut microbiome maturity compared with typically developing children. They had an underdeveloped gut bacteria that is not related to their diet. The research team examined stool samples of children with autism and identified significantly fewer bacteria linked to neurotransmitter activities and five unique species of bacteria that are not typically found in the guts of children without the condition. These findings recently published in an international medical journal Gut highlights the potential of non-invasive bacteria markers for early diagnosis and treatment for children with autism.

 

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and  Identifies Faecal Bacterial Markers for Autism

CU Medicine reports a ground breaking discovery that children with autism show delayed gut microbiome maturity compared with typically developing children.

(From left) Professor Francis CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research; Dr. Dorothy CHAN, Clinical Associate Professor (honorary), Department of Paediatrics; Dr. Sandra CHAN, Clinical Associate Professor, Department of Psychiatry; and Professor Siew NG, Associate Director, Centre for Gut Microbiota Research, CU Medicine.

Gut microbiome has a close connection with the pathogenesis of autism

 

Autism is a neurodevelopmental disorder characterised by the impairment of communication, the use of language and social interactions. Like most disorders that affect the brain, there is no one cause. It is believed that autism develops from a combination of genetic and environmental factors. Emerging research suggest that gut microbes communicate with the brain, dubbed the microbiome-gut-brain axis, and may account for the symptoms of autism. The prevalence of autism is approximately 1% in developed countries1, hence based on this estimation, there will be over 70,000 people with this condition in Hong Kong, and incidence has been on the rise in recent years.

 

Dr. Sandra Sau Man CHAN, Clinical Associate Professor of the Department of Psychiatry at CU Medicine elaborated, “Apart from genetic factors, it has been suggested that the gut microbiome may have a part to play in autism spectrum disorders. The evidence suggests that the pathway between gut bacteria and the central nervous system, referred to as the gut–brain axis, has a profound effect on social behaviours. Physicians and researchers are working hard to identify modifiable factors such as the microbiome which shall bring hope to children with autism and their families.”

 

Dr. Dorothy Fung Ying CHAN, Clinical Associate Professor (honorary) of the Department of Paediatrics at CU Medicine added, “Diagnosis of autism is currently carried out through regular developmental assessment for young children. Further clinical evaluation will only be offered to children when they show signs of atypical social and language development which is not satisfactory. The earlier autism is diagnosed and thus treated, the more effective and long-lasting the effects are. Research has shown that if children get early intervention, it’s more likely that they won’t need intensive support in elementary school and beyond”.

 

Emerging studies suggest that the gut microbiome may have a significant part to play in autism. The evidence suggests that the pathway between gut bacteria and the central nervous system, referred to as the gut–brain axis, has a profound effect on social behaviours.

 

Dr. Sandra Chan

Dr. Sandra Chan points out that there is evidence suggesting the gut–brain axis has a profound effect on social behaviours.

Dr. Dorothy Chan

Dr. Dorothy Chan remarks in the press conference that there are researches showing if children get early intervention, it’s more likely that they will not need intensive support in elementary school and beyond.

Children with autism had significantly fewer gut bugs linked to neurotransmitter activity

 

CU Medicine researchers tested whether children with autism harbour gut microbiome that differs significantly from that of typically developing children, which might facilitate early diagnosis or treatment. They compared the range, volume, and associated functions of bacteria in the stool samples of 128 Chinese children aged 3-6, half of whom had autism spectrum disorder. Below are the major findings:  

 

  1. The gut microbiome composition in children with autism differed substantially from that of children without the condition, with five bacterial species largely accounting for the difference. The sensitivity of these bacterial markers to identify autism is over 80%.
  2. Several Clostridium species enriched in children with autism. Clostridia species have been linked with autism via the production of clostridial toxins which can damage the central nervous system.
  3. Bacteria associated with neurotransmitter activities were substantially reduced in children with autism.
  4. The amount and abundance of gut microbiota shall grow with age but that of children with autism is abnormally developed and lags that of age-matched peers.

 

Prof. Siew Ng

Prof. Siew Ng states that the development of microbial communities within the gastrointestinal tract during childhood represents a critical window of human growth and health.

Prof. Francis Chan
Professor Francis Chan states that future therapeutics targeting reconstitution of gut microbiota in early life and increasing abundance of neurotransmitter-synthesised bacteria should be explored for autism.

Professor Siew Chien NG, Associate Director of the Centre for Gut Microbiota Research at CU Medicine remarked, “Our study shows for the first time that the gut microbiota of children with autism is abnormally developed and lags that of age-matched peers. As the development of microbial communities within the gastrointestinal tract during childhood represents a critical window of human growth and health, shifts in the gut microbiota during early life development may have important functional roles in the pathogenesis of autism and thus warrants extensive investigation.”

 

Professor Francis KL CHAN, Dean of Medicine and Director of the Centre for Gut Microbiota Research at CU Medicine, concluded, “We are hopeful that our findings could resolve the unmet need of autism diagnosis. Our study supports the potential role of non-invasive prediction of autism based on faecal bacteria markers and age-related bacteria development profile. Future therapeutics targeting reconstitution of gut microbiota in early life and increasing abundance of neurotransmitter-synthesised bacteria should be explored for autism spectrum disorder.”

 

The study was supported by the Health and Medical Research Fund of the Food and Health Bureau and InnoHK of the Innovation and Technology Commission of the HKSAR government.

 

Sun, X., Allison, C., Matthews, F.E. et al. Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. Molecular Autism 4, 7 (2013). https://doi.org/10.1186/2040-2392-4-7

More Press Releases

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Research
CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

Research
CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

Research
CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

Symposium
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
CUHK Develops Automatic Retinal Image Analysis Technology for Identifying Autism Making Objective Screening and Early Intervention Possible

CUHK Develops Automatic Retinal Image Analysis Technology for Identifying Autism Making Objective Screening and Early Intervention Possible

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Develops Resource Kit to Enhance Social Skills Among Autistic Students To be Promoted to All Local Schools

CUHK Develops Resource Kit to Enhance Social Skills Among Autistic Students To be Promoted to All Local Schools

Health Campaign

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.